Literature DB >> 2226550

Intravenous immunoglobulin in Diamond-Blackfan anaemia.

S Miceli Sopo1, M A Pesaresi, M Pastore, A Stabile.   

Abstract

Since immunological disorders have been demonstrated in patients with Diamond-Blackfan anaemia (DBA), intravenous immunoglobulins (IVIG) were administered to a 14-year-old girl with DBA and congenital malformations, previously treated with corticosteroids and blood transfusions. No therapeutic effect was observed.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2226550     DOI： 10.1007/bf01957279

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  10 in total

1.  High-dose intravenous methylprednisolone for refractory or resistant Diamond-Blackfan anemia.

Authors:  S Ozseylu
Journal:  Eur J Haematol       Date:  1987-08       Impact factor: 2.997

2.  Normal erythropoietic helper T cells in congenital hypoplastic (Diamond-Blackfan) anemia.

Authors:  D G Nathan; D G Hillman; L Chess; B P Alter; B J Clarke; J Breard; D E Housman
Journal:  N Engl J Med       Date:  1978-05-11       Impact factor: 91.245

3.  Treatment of pure red cell aplasia by high dose intravenous immunoglobulins.

Authors:  J P Clauvel; W Vainchenker; A Herrera; K Dellagi; G Vinci; A Tabilio; C Lacombe
Journal:  Br J Haematol       Date:  1983-10       Impact factor: 6.998

4.  High-dose intravenous gamma globulin for autoimmune neutropenia.

Authors:  S Pollack; C Cunningham-Rundles; E M Smithwick; S Barandun; R A Good
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

5.  Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.

Authors:  W Wiktor-Jedrzejczak; C Szczylik; Z Pojda; M Siekierzynski; J Kansy; M Klos; M Z Ratajczak; J Pejcz; D Jaskulski; P Gornas
Journal:  Eur J Haematol       Date:  1987-02       Impact factor: 2.997

6.  Diamond-Blackfan syndrome: evidence for T-cell mediated suppression of erythroid development and a serum blocking factor associated with remission.

Authors:  M H Steinberg; M F Coleman; J B Pennebaker
Journal:  Br J Haematol       Date:  1979-01       Impact factor: 6.998

7.  Bone-marrow microenvironment defect in congenital hypoplastic anemia.

Authors:  W B Ershler; J Ross; J L Finlay; N T Shahidi
Journal:  N Engl J Med       Date:  1980-06-12       Impact factor: 91.245

8.  Congenital hypoplastic anemia inhibition of erythropoiesis by sera from patients with congenital hypoplastic anemia.

Authors:  J A Ortega; N A Shore; P P Dukes; D Hammond
Journal:  Blood       Date:  1975-01       Impact factor: 22.113

9.  Diamond-Blackfan syndrome: a possible role of cellular factors for erythropoietic suppression.

Authors:  K Sawada; Y Koyanagawa; S Sakurama; S Nakagawa; T Konno
Journal:  Scand J Haematol       Date:  1985-08

10.  Cyclosporine in steroid-resistant Diamond-Blackfan anaemia.

Authors:  M Seip; G F Zanussi
Journal:  Acta Paediatr Scand       Date:  1988-05
  10 in total
  2 in total

Review 1.  Do ribosomopathies explain some cases of common variable immunodeficiency?

Authors:  S Khan; J Pereira; P J Darbyshire; S Holding; P C Doré; W A C Sewell; A Huissoon
Journal:  Clin Exp Immunol       Date:  2010-11-09       Impact factor: 4.330

Review 2.  Progress towards mechanism-based treatment for Diamond-Blackfan anemia.

Authors:  Sara E Sjögren; Johan Flygare
Journal:  ScientificWorldJournal       Date:  2012-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.